Researchers have discovered how the mechanical properties of tumors can prime cancer cells to better survive their spread to other organs.
Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancer
Biomarker-directed thromboprophylaxis in the outpatient setting significantly reduced the frequency of thromboembolism in high-risk patients with gastrointestinal (GI) or lung cancers, a randomized trial showed.